American Journal of Epidemiology Vol. 153, No. 6 : 610-614
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Incidence of Guillain-Barré Syndrome following Infection with Campylobacter jejuni
1 Swedish Institute for Infectious Disease Control, SE-171 82, Solna, Sweden.
2 European Programme for Intervention Epidemiology Training, European Commission, European Union, Brussels, Belgium.
3 Karolinska Institute, SE-171 77, Solna, Sweden.
Evidence of recent or ongoing Campylobacter jejuni infection has been found in approximately one out of every four cases of Guillain-Barré syndrome (GBS). It is increasingly accepted that C. jejuni infection is an important causal factor for GBS. However, the likelihood of GBS' occurring following an episode of C. jejuni gastroenteritis has not been measured. The authors measured the incidence of GBS in a large cohort of persons with laboratory-confirmed C. jejuni infection. Cases of C. jejuni infection were derived from the Swedish national laboratory reporting system for the years 1987–1995. Follow-up for GBS was carried out using the Swedish national hospital inpatient register. Nine cases of GBS were detected in the cohort, which comprised 29,563 cases of C. jejuni infection—a rate of 30.4 per 100,000 (95% confidence interval: 13.9, 57.8). This compares with an expected incidence of 0.3 per 100,000 in a 2-month period in the general population. GBS is an important but rare complication of C. jejuni infection. The risk of developing GBS during the 2 months following a symptomatic episode of C. jejuni infection is approximately 100 times higher than the risk in the general population.
Campylobacter infections; Campylobacter jejuni; incidence; polyradiculoneuritis
Abbreviations: GBS, Guillain-Barré syndrome.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kaida, T. Ariga, and R. K Yu Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review Glycobiology, July 1, 2009; 19(7): 676 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. R. Louis, I. A. Gillespie, S. J. O'Brien, E. Russek-Cohen, A. D. Pearson, and R. R. Colwell Temperature-Driven Campylobacter Seasonality in England and Wales Appl. Envir. Microbiol., January 1, 2005; 71(1): 85 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Potter, J. B. Kaneene, and W. N. Hall Risk Factors for Sporadic Campylobacter jejuni Infections in Rural Michigan: A Prospective Case-Control Study Am J Public Health, December 1, 2003; 93(12): 2118 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Molinero, D. Varon, K. R. Holden, J. T. Sladky, I. B. Molina, and F. Cleaves Epidemiology of Childhood Guillain-Barre Syndrome as a Cause of Acute Flaccid Paralysis in Honduras: 1989--1999 J Child Neurol, November 1, 2003; 18(11): 741 - 747. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Zia, D. Wareing, C. Sutton, E. Bolton, D. Mitchell, and J. A. Goodacre Health problems following Campylobacter jejuni enteritis in a Lancashire population Rheumatology, September 1, 2003; 42(9): 1083 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Weinberg, N. McCarthy, and J. Giesecke RE: "INCIDENCE OF GUILLAIN-BARRE SYNDROME FOLLOWING INFECTION WITH CAMPYLOBACTER JEJUNI" Am. J. Epidemiol., September 15, 2001; 154(6): 590 - 590. [Full Text] [PDF]
|
|